Class II transactivator: Is it a master switch for MHC class II gene expression?

Microbes and Infection

Volumn 1, Issue 11, 1999, Pages 879-885

  Chang, Cheong Hee ^a   Roys, Stacey ^a   Gourley, Tania ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0032744028     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00230-0     Document Type: Article

References (63)

1. Arany Z., Newsome D., Oldread E., Livingston D.M., Eckner R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature. 374:1995;81-84.
2. Ardavin C., Wu L., Li C.L., Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature. 362:1993;761-763.
3. Benichou B., Strominger J.L. Class II-antigen-negative patient and mutant B-cell lines represent at least three and probably four distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA. 88:1991;4285-4288.
4. Chang C.H., Flavell R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. M. 181:1995;765-766.
5. Chang C.H., Fontes J., Peterlin M., Flavell R.A. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. M. 180:1994;1367-1374.
6. Chang C.H., Guerder S., Hong S.C., Van Ewijk W., Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:1996;167-178.
7. Chang C.H., Hong S.C., Hughes C.C.W., Janeway C.A.J., Flavell R.A. CIITA activates the expression of MHC class II genes in mouse T cells. Int. Immunol. 7:1995;1515-1518.
8. Chin K.C., Li G.G.X., Ting J.P.Y. Importance of acidic proline/serine/threonine-rich and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA. 94:1997;2501-2506.
9. Chin K.C., Mao C., Skinner C., Riley J.L., Wright K.L., Moreno C.S., Stark G.R., Boss J.M., Ting J.P.Y. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity. 2:1994;533-543.
10. Chin K.C., Li G., Ting J.P. Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal class II transactivator deletion mutants. J. Immunol. 159:1997;2789-2794.
11. Clausen B.E., Waldburger J.M., Schwenk F., Barras E., Mach B., Rajewsky K., Forster I., Reith W. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity. 8:1998;143-155.
12. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:1997;297-322.
13. Dunaief J.L., Strober B.E., Guha S., Khavari P.A., Alin K., Luban J., Begemann M., Crabtree G.R., Goff S.P. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell. 79:1994;119-130.
14. Durand B., Sperisen P., Emery P., Barras E., Zufferey M., Mach B., Reith W. RFXAP a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1997;1045-1055.
15. Fazekas D.E., St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today. 19:1998;448-454.
16. Fontes J.D., Jabrane-Ferrat N., Toth C.R., Peterlin B.M. Binding and cooperative interactions between two B cell-specific transcriptional coactivators. J. Exp. M. 183:1996;2517-2521.
17. Fontes J.D., Jiang B., Peterlin B.M. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25:1997;2522-2528.
18. Gansbacher B., Zier K. HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium. Clin. Exp. Immunol. 76:1989;440-445.
19. Gobin S.J., Peijnenburg A., Keijsers V., Van Den Elsen P.J. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity. 6:1997;601-611.
20. Gutch M.J., Reich N.C. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA. 88:1991;7913-7917.
21. Hasegawa S.L., Boss J.M. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters. Nucleic Acids Res. 19:1991;6269-6276.
22. Hooft VanHuijsduijnen R., Li X.Y., Black D., Matthes H., Benoist C., Mathis D. Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO. 9:1990;3119-3127.
23. Hume C.R., Accolla R.S., Lee J.S. Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes. Proc. Natl. Acad. Sci. USA. 84:1987;8603-8607.
24. Kalvakolanu D.V., Bandyopadhyay S.K., Harter M.L., Sen G.C. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA. 88:1991;7459-7463.
25. Kara C.J., Glimcher L.H. In vivo footprinting of MHC class II genes: Bare promoters in the Bare Lymphocyte Syndrome. Science. 252:1991;709-712.
26. Kern I., Steimle V., Siegrist C.A., Mach B. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7:1995;1295-1299.
27. Ko H., Fu S., Winchester R., Yu D., Kunkel H. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J. Exp. M. 150:1979;246-255.
28. Kretsovali A., Agalioti T., Spilianakis C., Tzortzakaki E., Merika M., Papamatheakis J. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18:1998;6777-6783.
29. Lee Y.J., Benveniste E.N. Stat1α expression is involved in IFN-γ induction of the class II transactivator and class II genes. J. Immunol. 157:1996;1559-1568.
30. Lorber M.I., Loken M.R., Stall A.M., Fitch F.W. I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. J. Immunol. 128:1982;2798-2803.
31. Lu Y., Boss J.M., Hu S.X., Xu H.J., Blanck G. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction. J. Immunol. 156:1996;2495-2502.
32. Lu Y., Ussery G.D., Muncaster M.M., Gallie B.L., Blanck G. Evidence for retinoblastoma protein (RB) dependent and independent IFN-γ response: RB coordinately rescues IFN-γ induction of MHC class II gene transcription in noninducible breast carcinoma cells. Oncogenes. 9:1994;1015-1019.
33. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes: Lessons from a disease. Annu. Rev. Immumol. 14:1996;301-331.
34. Mahanta S.K., Scholl T., Yang F.C., Strominger J.L. Transactivation by CIITA: the type II bare lymphocyte syndrome-associated factor requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA. 94:1997;6324-6329.
35. Martin B.K., Chin K.C., Olsen J.C., Skinner C.A., Dey A., Ozato K., Ting J.P. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity. 6:1997;591-600.
36. Meraz M.A., White J.M., Sheehan K.C.F., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., Dubois R.N., Clark R., Aguet M., Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAk-STAT signaling pathway. Cell. 94:1996;431-442.
37. Moreno C.S., Emery P., West J.E., Durand B., Reith W., Mach B., Boss J.M. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:1995;4313-4321.
38. Muhlethaler-Mottet A., Berardino W.D., Otten L.A., Mach B. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity. 8:1998;157-166.
39. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851-2860.
40. Niederhuber J.E., Frelinger J.A. Expression of Iα antigens on T and B cells and their relationship to immune-response functions. Transplant. Rev. 30:1976;101-121.
41. Osborne A., Tschickardt M., Blanck G. Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter. Nucleic Acids Res. 25:1997;5095-5102.
42. Peterson C.L., Tamkun J.W. The SWI-SNF complex: a chromatin remodeling machine? Trends in Biochem. Sci. 20:1995;143-146.
43. Pichler W.J., Wyss-Coray T. T cells as antigen-presenting cells. Immunol. Today. 315:1994;312-315.
44. Piskurich J.F., Wang Y., Linhoff M.W., White L.C., Ting J.P.Y. Identification of distinct regions of 5' flanking DNA that mediate constitutive IFN-γ, Stat1, and TGF-α-regulated expression of the class II transactivator gene. J. Immunol. 160:1998;233-240.
45. Reith W., Satola S., Herrero Sanchez C., Lisowskagrospeire B., Griscelli C., Hadam M.R., Mach B. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein RF-X. Cell. 53:1988;897-906.
46. Reith W., Siegrist C.A., Durand B., Barras E., Mach B. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA. 91:1994;554-558.
47. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 2:1995;533-543.
48. Scholl T., Mahanta S.K., Strominger J.L. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA. 94:1997;6330-6334.
49. Seidl C., Saraiya C., Osterweil Z., Fu Y.P., Lee J.S. Genetic complexity of regulatory mutants defective for HLA class II gene expression. J. Immunol. 148:1992;1576-1584.
50. Shikama N., Lyon J., LaThangue N. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7:1997;230-236.
51. Silacci P., Mottet A., Steimle V., Reith W., Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. M. 180:1994;1329-1336.
52. Singh P., Coe J., Hong W. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature. 374:1995;562-565.
53. Steimle V., Durand B., Barras E., Zufferey M., Hadam M., Mach B., Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1995;1021-1032.
54. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell. 75:1993;135-146.
55. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science. 265:1994;106-109.
56. Thomas D.B., Smith C.A., Graham C.M. Viral peptide specific induction of MHC class II expression by murine T cell clones. J. Immunol. 157:1996;2386-2394.
57. Van Ewijk W., Ron Y., Monaco J., Kappler J., Marrack P., LeMeur M., Gerlinger P., Durand B., Benoist C., Mathis D. Compartmentalization of MHC class II gene expression in transgenic mice. Cell. 53:1988;357-370.
58. Vremec D., Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers changes with incubation and differences among thymus spleen and lymph nodes. J. Immunol. 159:1997;565-573.
59. Williams G.S., Malin M., Chang C.H., Boyd R., Benoist C., Mathis D. Mice lacking the transcription factor CIITA a second look. Int. Immunol. 10:1998;1957.
60. Wright K.L., Chin K.C., Linhoff M., Skinner C., Brown J.A., Boss J.M., Stark G.R., Ting J.P.Y. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;6267-6272.
61. Wu L., Li C.L., Shortman K. Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J. Exp. M. 184:1996;903-911.
62. Wu L., Nichogiannopoulou A., Shortman K., Georgopoulos K. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity. 7:1997;483-492.
63. Zhou H., Glimcher L.H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA one of the defective genes in type II MHC combined immune deficiency. Immunity. 2:1995;545-553.